Status:
COMPLETED
False/Negative Rate of Lung Percutaneous Needle Biopsy
Lead Sponsor:
State University of New York - Upstate Medical University
Conditions:
Lung Neoplasm
Eligibility:
All Genders
18+ years
Brief Summary
Needle biopsy is a way of determining whether a lung mass is cancerous or benign. Its accuracy was established by research in which patients underwent fine needle aspiration, a kind of needle biopsy t...
Detailed Description
We will review medical records to identify patients who underwent percutaneous needle biopsy of a lung mass between 5/1/01 and 10/30/04. If the pathology report indicates that the biopsy showed no evi...
Eligibility Criteria
Inclusion
- subjects who underwent percutaneous needle biopsy of a lung mass during the study period of 5/1/01 to 10/30/04
Exclusion
- subjects will be excluded if at least one core sample was not obtained in the course of the biopsy.
- subjects who had a pathology sample read as "insufficient for diagnosis"
- subjects who underwent needle biopsy only for infection, to identify a causative organism
Key Trial Info
Start Date :
March 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2010
Estimated Enrollment :
5 Patients enrolled
Trial Details
Trial ID
NCT00638352
Start Date
March 1 2010
End Date
April 1 2010
Last Update
December 15 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
SUNY Upstate Medical University
Syracuse, New York, United States, 13210